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Aim: The aim of this study was to evaluate the bone 
formation in surgically created defects of rabbit mandibles 
by synthetic hydroxyapatite of calcium compared to small 
Intestine Submucosa. Material and Method: 24 mices 
lineage Wisthar-Furth were used. A bony defect of 0,75 
cm x 1,5 cm in mandibular ramus was accomplished in all 
animals. The hydroxyapatite implants were placed on the 
left hemimandiblein groupI, small Intestine submucosa in 
group II, and the right served as control. The euthanasia 
was accomplished in the 40° postoperative day, it was 
proceeded the macroscopic and histological analysis. Results: 
medium length in millimeters of the hemimandibless in the 
hydroxyapatite group was of 3,75, in the small intestine 
submucosa 3,03 and the control group was of 2,63 (p: 
0,022). Histomorphometry study reaveled new bone grown 
in 76,64% of the total area in hydroxyapatite group (p: 0,022). 
In Small Intestinal submucosa group new bone grown in 
63,64% do total (p: 0,0022). Discussion: satisfactory bone 
integration was observed of the synthetic hydroxyapatite in 
that experimental model. Small intestinal submucosa cause 
osteoinduction Conclusion: using hydroxyapatite of calcium 
resulted in formation of significantly larger volume frations 
of new bone when compared to small intestinal submucosa 
group.
Key words: defect repair ,hydroxyapatite, small intestine 
submucosa.
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INTRODUCTION
Many biomaterials are being tested because they can 
cause bone regeneration, such as: calcium hydroxyapatite 
and tricalcium phosphate1. All these porous synthetic sur-
rogates share advantages in relation to auto and allografts, 
including their easy sterilization and storage, and their 
unlimited availability. Among their disadvantages we have: 
delicate handling, variable degrees of resorption, poor 
performance in diaphysis defects and potential adverse 
effects on bone remodeling2.
Synthetic hydroxyapatite, [CaIO(PO4)(OH)], is an 
inorganic material commonly used in bone gaps and as a 
constituent in the mineral phase of calcified tissues. It is 
biocompatible and bears osteoconduction, and this makes 
it the most important bone surrogate of modern times; 
because it is used in bone defects without load or in gaps 
in which loads, tortional stresses or shearing forces are 
neutralized by rigid implants such as plates and screws3.
Bone regeneration promoted by hydroxyapatite has 
been studied in different animal and human models. Its 
first implants in animal models were made in proximal 
tibial defects in dogs. A fast graft incorporation was seen 
after graft implant, no adverse effects, bringing about high 
bone regeneration4.
The porcine Small Intestine Submucosa (SIS) is a 
multilaminar acellular layer made up mostly of collagen 
that has shown to have characteristics that make it a proper 
material for tissue bioengineering in different anatomical 
sites5.
According to many authors, SIS has the advantage 
of being made up of 90% type I collagen, fibronectines, 
growth factors, glycosaminoglycans, protaminoglycans and 
glycoproteins6. Since it is an acellular tissue, fribonectine is 
the element responsible for inducing local celularity7.
As to the immune reactions triggered by porcine SIS, 
Metzger et al. concluded that this membrane induces an 
immune response in rats, activating T-helper-2 cells8. There 
was also a drop in the levels of inflammatory cytokines, 
as well as of alpha tumoral necrosis factor, IL I and IL VI. 
The authors concluded that porcine SIS does not promote 
rejection reactions when implanted.
Hodde et al. advocate that this capacity is due to 
the presence of glycosaminoglycans in SIS, which are 
able to activate numerous cytokines and growth factors 
that participate in healing and revascularization processes, 
thanks to the presence of vascular endothelial growth 
factor (VEGF), which is able to induce the formation of 
similar structures, and fenestrated capillaries in the fibrin 
matrix9.
The objective of the present study is to evaluate 
bone regeneration in a bone defect created in rat man-
dibles, comparing two biomaterials, synthetic calcium 
hydroxyapatite and porcine small intestine submucosa.
MATERIALS AND METHODS
In performing this study we respected the rules of 
the Brazilian College of Animal experimentation (COBEA). 
We used 24 adult rats from the Wisthar-Furth lineage, 
weighing between 180 and 220 grams. They were kept in 
proper environment under natural lighting and tempera-
ture, and fed water and ration ad libitum.
The animals were anesthetized via intramuscular 
injection of Ketamine 40 mg/kg, Diazepam 2 mg/kg and 
Butorphanol 2 mg/kg. A 3cm incision was made in order 
to expose the mandible. A 0.75cm x 1.5cm bone defect 
was created on the body of each mandible in all animals 
using a low RPM Sorensen® # 7.5 spherical burr.
The animals were divided in two groups: group 
I received filling with caustic hydroxyapatite in the left 
mandible and group II had the left side bone defect filled 
with porcine small intestine submucosa.
Prophylaxis was carried out with antibiotics during 
the procedure with cephazolin 0.01 ml/kg. Such animals 
remained in single cages, with controlled lighting and ad 
libitum diet. The animals were slaughtered on the 40th 
day of postop.
Macroscopic analysis was carried out through 
measuring the diameter of bone calluses (growth). For 
microscopic analysis the specimens were sent to be fixed 
in paraffin and were later processed according to conven-
tional hystology techniques, and later on they were dyed 
with hematoxylin-eosin. For morphometric assessment 
we carried out 6 measurements in 6 different microscopic 
fields. This evaluation was carried out using the Image 
Pro-Plus software, coupled to a Sony video camera and a 
BX 50 microscope, calibrating the magnification for a 10x 
lens, using the area morphometric application through 
a difference in color between bone tissue and the con-
nective tissue highlighted by dyeing. We assessed bone 
neoformation, area porosity, amount of mature bone and 
immature bone.
For statistical analysis of the macroscopic varieties 
(diameter), we used Wilcoxon’s non-parametric test. And 
for histology analysis (porosity percentage, percentage of 
new bone formed, percentage of mature bone, percentage 
of immature bone) we used the binomial test. We set in 5% 
(p< 0.05) the level of rejection for the null hypothesis.
RESULTS
As for the clinical analysis, all the animals remained 
healthy and did not have complications in their post-op-
erative outcome, except for one animal from Group I and 
two animals from Group II that had bone infection and 
were removed from the study.
The macroscopic analysis showed a greater forma-
tion of bone callous in the group that received hydroxya-
patite, when compared to the group that received small 
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intestine submucosa. The average length, in millimeters, 
of the hemi mandibles of the hydroxyapatite group was 
3.75; in the small intestine submucosa group was 3.03; and 
the control group had 2.63 (p: 0.0022) in length. Groups 
I and II had better results when compared to the control 
group, without the use of any graft.
Area morphometry showed that the control group 
(without any graft) had bone neoformation in 28.40% and 
porosity remained in 71.59%.
The group with hydroxyapatite had bone area neo-
formation corresponding to 76.64% of the total (p: 0.0022). 
Of this neoformed bone, 83.77% already was mature bone. 
In this same evolutionary stage, the control group showed 
only 24.88% (Figure 2).
In the group with porcine SIS, bone neoformation 
added up to a corresponding area of 63.64% of the total 
(p: 0.0022). Of this neoformed bone, 63.77% already was 
mature bone at in this same evolutionary stage, the control 
group had only 36.23% (p: 0.0025).
DISCUSSION
Recently, literature has shown promising results as 
to the use of SIS grafts in different anatomical structures, 
such as the urinary bladder, urethra, tendons, esophagus, 
arteries, veins and abdominal wall10,11.
After implantation there is a fast neovascularization, 
infiltration and spatial organization. This may be seen in 
Sanduski’s study, in which seven days after SIS implant in 
canine carotid arteries the observed a fibrin coating and 
neointima in the graft, and in the 90th day of post-op, the 
SIS implant site was equal to that of a normal artery12,13.
About immune reactions triggered by porcine SIS, 
Metzger et al. (1997) concluded that this membrane in-
duces immune response and activates T-helper 2 cells in 
rats and they also saw a reduction in the levels of inflam-
matory cytokines, as well as alpha tumoral necrosis factor 
an IL 1 and 6. The authors concluded that porcine SIS does 
not promote rejection reaction when implanted7.
Badylak el al. (1995), in an experimental study in 
which they caused an intentional infection by Staphylo-
coccus aureus, in order to compare SIS with polyetraflu-
oretilene, and had 56% of infection rate in synthetic 
prosthesis and 0% in porcine SIS15-17.
According to Hodde et al., the porcine small intes-
tine submucosa (SIS) induces bone conduction and thus 
facilitates the filling up of a bone defect that was been 
surgically created. It acts as an optimal repair material and 
induces medullar cells growth in the graft bone neoforma-
tion, thus promoting a fast cartilage formation as well9.
Hydroxyapatite has been approved for human 
use by the American Food and Drug Administration 
(FDA) only for metaphysis traumatic defects. However, it 
has been used in daily medical practice in a number of 
situations18.
Bone graft incorporation happens in 5 stages: 1) 
inflammatory - causing an inflammatory response in the 
host; 2) tissue revascularization; 3) bone conduction, in 
which the graft functions as a framework for the growth 
of vessels and bone formation; 4) osteoinduction, in which 
host mesenchimal cells are induced by proteins (BMP) 
found in the graft and change into osteoblasts, and 5) 
bone remodeling with characteristics of continuous bone 
formation and resorption5.
Kühne et al. made a radiological and histological 
assessment of coral porous hydroxyapatite in an experi-
mental study in rabbits. The implants were carried out in 
their femoral condiles in order to repair empty cavities, 
thus proving bone integration when porous hydroxyapa-
tite is used19.
Uchida et al. carried out an experimental study in 
rabbits by implanting sea coral duplicated ceramics in 
standard bone defects, proving bone graft integration. In 
the present study we saw a greater formation of a mac-
roscopic bone callous in the hydroxyapatite group, when 
we could observe the graft-implant integration20.
Bucholz et al. compared the coral porous hy-
droxyapatite applicability or autogenous bone graft for the 
treatment of tibial fractures in humans, and did not find 
significant differences between the two groups, proving 
the possibility of using hydroxyapatite in bone defects2. 
Yamamoto et al. used hydroxyapatite to fill up defects 
after the excision of benign bone tumors and achieved 
total radiographic graft incorporation 3 months after its 
implant21.
Karabatsos et al. implanted hydroxyapatite in the 
femur of a canine model and obtained significant bone 
integration in the graft-implant interface4.
The microscopic analysis tried to assess the mor-
phometry of the region where the bone defect was created, 
observing an abundant bone neoformation in 76.64% of 
the hemi mandibles in which hydroxyapatite was used, as 
well as an advanced level of bone maturation, since 83.77% 
of the neoformed bone bore mature bone characteristics. 
Porcine SIS also proved to be a good osteoconductor; 
however the level of bone neoformation was greater in 
the hydroxyapatite group.
We could see satisfactory porous hydroxyapatite 
integration to the mandible bone in this experimental 
model. Macroscopic, radiologic and microscopic results 
were better when this type of graft was used when com-
pared to the group that received submucosa. However, 
both grafts had bone induction results which were clearly 
better when compared to the control group.
Future experiments in this same line of research 
must be implemented, using other animal models that al-
low the creation of an anatomical larger bone defect and 
that can have a longer post-surgery time.
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Figure 1a. Perforation in the rat mandible - We see the mandible per-
foration with the low RPM 7.5 Sorense burr.
Figure 1b. Filling the bone defect created with caustic hydroxyapa-
tite.
Figure 2a. Hematoxylin and eosin slide in a specimen from the control 
group.
Figure 2b. Slide dyed with HE from the hydroxyapatite group - We 
see bone neoformation.
CONCLUSION
SIS seemed to make it easier to fill up the surgical 
defect created in rat mandibles. Further studies are neces-
sary in order to better define the cellular basis for this activ-
ity, as well as the assessment of potential SIS applications 
in grafts to repair bone gaps in human beings.
Coral porous hydroxyapatite integrated to the recipi-
ent experimental bone model, allowing early and adequate 
bone neoformation.
When we compare both biografts, coral hydroxya-
patite achieved better results.
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